![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NAPRT1 |
Gene summary for NAPRT1 |
![]() |
Gene information | Species | Human | Gene symbol | NAPRT1 | Gene ID | 93100 |
Gene name | nicotinate phosphoribosyltransferase | |
Gene Alias | NAPRT1 | |
Cytomap | 8q24.3 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q6XQN6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
93100 | NAPRT1 | Pt13.a | Human | Liver | HCC | 5.18e-27 | 4.74e-01 | 0.021 |
93100 | NAPRT1 | Pt13.b | Human | Liver | HCC | 9.90e-52 | 6.77e-01 | 0.0251 |
93100 | NAPRT1 | Pt14.a | Human | Liver | HCC | 1.06e-18 | 5.97e-01 | 0.0169 |
93100 | NAPRT1 | Pt14.b | Human | Liver | HCC | 1.91e-25 | 7.07e-01 | 0.018 |
93100 | NAPRT1 | Pt14.d | Human | Liver | HCC | 7.14e-15 | 3.36e-01 | 0.0143 |
93100 | NAPRT1 | P1_S1_AK | Human | Skin | AK | 9.41e-05 | -9.94e-02 | -0.3399 |
93100 | NAPRT1 | P2_S3_AK | Human | Skin | AK | 4.43e-05 | -9.94e-02 | -0.3287 |
93100 | NAPRT1 | P2_S4_SCCIS | Human | Skin | SCCIS | 2.00e-04 | -9.94e-02 | -0.3043 |
93100 | NAPRT1 | P3_S6_AK | Human | Skin | AK | 4.43e-05 | -9.94e-02 | -0.3256 |
93100 | NAPRT1 | P5_S10_cSCC | Human | Skin | cSCC | 9.41e-05 | -9.94e-02 | -0.299 |
93100 | NAPRT1 | P1_cSCC | Human | Skin | cSCC | 3.21e-50 | 1.56e+00 | 0.0292 |
93100 | NAPRT1 | P2_cSCC | Human | Skin | cSCC | 3.40e-27 | 7.55e-01 | -0.024 |
93100 | NAPRT1 | P4_cSCC | Human | Skin | cSCC | 6.40e-37 | 9.22e-01 | -0.00290000000000005 |
93100 | NAPRT1 | P10_cSCC | Human | Skin | cSCC | 1.33e-38 | 1.10e+00 | 0.1017 |
93100 | NAPRT1 | cSCC_p1 | Human | Skin | cSCC | 4.43e-05 | -9.94e-02 | -0.1916 |
93100 | NAPRT1 | cSCC_p10 | Human | Skin | cSCC | 4.43e-05 | -9.94e-02 | -0.2095 |
93100 | NAPRT1 | cSCC_p11 | Human | Skin | cSCC | 4.43e-05 | -9.94e-02 | -0.2102 |
93100 | NAPRT1 | cSCC_p3 | Human | Skin | cSCC | 4.43e-05 | -9.94e-02 | -0.2085 |
93100 | NAPRT1 | cSCC_p4 | Human | Skin | cSCC | 4.01e-03 | -9.94e-02 | -0.2022 |
93100 | NAPRT1 | cSCC_p6 | Human | Skin | cSCC | 2.00e-04 | -9.94e-02 | -0.1989 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa012405 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa0124012 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa01240 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa012401 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa012402 | Liver | HCC | Biosynthesis of cofactors | 103/4020 | 153/8465 | 4.67e-07 | 5.05e-06 | 2.81e-06 | 103 |
hsa012403 | Liver | HCC | Biosynthesis of cofactors | 103/4020 | 153/8465 | 4.67e-07 | 5.05e-06 | 2.81e-06 | 103 |
hsa012404 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
hsa0124011 | Oral cavity | OSCC | Biosynthesis of cofactors | 88/3704 | 153/8465 | 3.84e-04 | 1.20e-03 | 6.12e-04 | 88 |
hsa0124021 | Oral cavity | LP | Biosynthesis of cofactors | 57/2418 | 153/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 57 |
hsa0124031 | Oral cavity | LP | Biosynthesis of cofactors | 57/2418 | 153/8465 | 1.17e-02 | 3.91e-02 | 2.52e-02 | 57 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |